ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MPH Mereo Biopharma Group Plc

26.50
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mereo Biopharma Group Plc LSE:MPH London Ordinary Share GB00BZ4G2K23 ORD GBP0.003 (REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.50 26.00 27.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Capital Reorganisation

16/10/2003 12:34pm

UK Regulatory


RNS Number:9732Q
Marchpole Holdings PLC
16 October 2003

For immediate release

                                                                 16 October 2003

                  Marchpole Holdings PLC (the "Company")

                       Capital reduction approval

On 3 October 2003 Marchpole Holdings PLC announced that a hearing was due to be
held on 15 October 2003 at which the High Court would consider the proposed
reduction of share capital of the Company and of amounts standing to the
Company's share premium account which shareholders approved on 1 September 2003.

The hearing took place on 15 October and the High Court approved the proposals.

The reduction comprises a reduction of #22,696,368.11 by means of the
cancellation of the entire class of 2,269,636,811 deferred shares of 1p each and
the reduction of amounts standing to the Company's share premium account by
#14,070,000.  The number of ordinary shares in issue and the amount paid up on
each such share will not be affected by the proposed reduction.



Enquiries:

Justin Hampshire, Marchpole Holdings          020 7908 7777

Simon Edwards, Shore Capital                  020 7408 4090



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

CARMFBBTMMJBBTJ

1 Year Mereo Biopharma Chart

1 Year Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

Your Recent History

Delayed Upgrade Clock